Comparison of Effects of Transforming Growth Factor-Beta and Cyclosporin A on Antigen-Presenting Cells of Blood and Epidermis
- 1 April 1991
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 96 (4), 401-407
- https://doi.org/10.1111/1523-1747.ep12469761
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Human Epidermal Langerhans Cells Undergo Profound Morphologic and Phenotypical Changes During In Vitro CultureJournal of Investigative Dermatology, 1990
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Cultured Human Langerhans Cells Resemble Lymphoid Dendritic Cells in Phenotype and FunctionJournal of Investigative Dermatology, 1989
- Quantitation of Surface Antigens on Cultured Murine Epidermal Langerhans Cells: Rapid and Selective Increase in the Level of Surface MHC ProductsJournal of Investigative Dermatology, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- INHIBITION OF HUMAN MONOCYTE ANTIGEN PRESENTATION, BUT NOT HLA-DR EXPRESSION, BY CYCLOSPORINETransplantation, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986
- Cyclosporin-A inhibits IL-2 production by all human T-cell clones having this function, independent of the phenotype or the coexpression of cytolytic activityClinical Immunology and Immunopathology, 1986
- INHIBITION OF THE ACCESSORY FUNCTION OF MURINE MACROPHAGES IN VITRO BY CYCLOSPORINETransplantation, 1985